NEUROGENETIC PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2009-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- NeuroGenetic Pharmaceuticals Inc
- Target Recruit Count
- 24
- Registration Number
- NCT02537938
- Locations
- 🇺🇸
WCCT Global, Cypress, California, United States
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose)
- First Posted Date
- 2015-08-27
- Last Posted Date
- 2016-01-13
- Lead Sponsor
- NeuroGenetic Pharmaceuticals Inc
- Target Recruit Count
- 40
- Registration Number
- NCT02534480
- Locations
- 🇺🇸
WCCT, Cypress, California, United States
News
No news found